IMMY

IMMY is a company that expands its diagnostic capabilities through the acquisition of OLM Diagnostics, focusing on innovative molecular diagnostics. With a strong emphasis on fungal infections, IMMY offers a range of products including lateral flow assays and enzyme immunoassays to aid in the accurate and timely diagnosis of various fungal diseases. Committed to improving patient care worldwide, IMMY leverages over 40 years of experience in the field to provide reliable testing solutions to healthcare professionals across more than 80 countries.